Chlorogenic acid reduces inflammation by inhibiting the elevated expression of KAT2A to ameliorate lipopolysaccharide‐induced acute lung injury
British Journal of Pharmacology · 2023-08 · 180 (16) · 2156-2171
DOI: 10.1111/bph.16069 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 19.04.2023. Verfasst von Bin Lv und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Ti…. Hauptthemen laut MEDLINE: Acute Lung Injury, Lipopolysaccharides. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Background and Purpose Respiratory diseases have become a global health problem and may lead to acute lung injury (ALI) in severe cases. ALI progression is associated with complex pathological changes; however, there are currently no effective therapeutic drugs. Excessive activation and recruitment of immunocytes in the lungs and the release of large amounts of cytokines are considered the primary causes of ALI, but the cellular mechanisms involved remain unknown. Therefore, new therapeutic strategies need to be developed to control the inflammatory response and prevent the further aggravation of ALI. Experimental Approach Lipopolysaccharide was administered to mice via tail vein injection to establish an ALI model. Key genes regulating lung injury in mice were screened by RNA sequencing (RNA‐seq), and their regulatory effects on inflammation and lung injury were assessed in in vivo and in vitro experiments. Key Results The key regulatory gene KAT2A up‐regulated the expression of inflammatory cytokines and induced lung epithelial injury. Chlorogenic acid, a small natural molecule and KAT2A inhibitor, inhibited the inflammatory response and significantly improved the decreased respiratory function caused by lipopolysaccharide administration in mice by inhibiting the expression of KAT2A. Conclusion and Implications Targeted inhibition of KAT2A suppressed the release of inflammatory cytokines and improved respiratory function in this murine model of ALI. Chlorogenic acid, a specific KAT2A‐targeting inhibitor, was effective in treating ALI. In conclusion, our results provide a reference for the clinical treatment of ALI and contribute to the development of novel therapeutic drugs for lung injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
- State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
- College of International Education, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
- College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
ORCID-Profile: Jinhe Guo, Xiaoying Wang
Zitieren
APA
Lv, B., Guo, J., Du, Y., Chen, Y., Zhao, X., Yu, B., Liu, J., Cui, T., Mao, H., Wang, X., & Gao, X. (2023). Chlorogenic acid reduces inflammation by inhibiting the elevated expression of KAT2A to ameliorate lipopolysaccharide‐induced acute lung injury. British Journal of Pharmacology, 180(16), 2156-2171. https://doi.org/10.1111/bph.16069
Vancouver
Lv B, Guo J, Du Y, Chen Y, Zhao X, Yu B, et al. Chlorogenic acid reduces inflammation by inhibiting the elevated expression of KAT2A to ameliorate lipopolysaccharide‐induced acute lung injury. British Journal of Pharmacology. 2023;180(16):2156-2171. doi:10.1111/bph.16069
BibTeX
@article{Lv2023,
author = {Lv, Bin and Guo, Jinhe and Du, Yaodong and Chen, Yang and Zhao, Xin and Yu, Bin and Liu, Jiarui and Cui, Tianyi and Mao, Haoping and Wang, Xiaoying and Gao, Xiumei},
title = {Chlorogenic acid reduces inflammation by inhibiting the elevated expression of KAT2A to ameliorate lipopolysaccharide‐induced acute lung injury},
journal = {British Journal of Pharmacology},
year = {2023},
volume = {180},
number = {16},
pages = {2156--2171},
doi = {10.1111/bph.16069}
}
EUVIMED